Proportion of infiltrating IgG-binding immune cells predict for tumour hypoxia

British Journal of Cancer

Volumn 84, Issue 5, 2001, Pages 626-630

  Collingridge, D R ^a   Hill, S A ^b   Chaplin, D J ^c  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c Oxigene Inc   (United States)

Author keywords

Angiogenesis; Flow cytometry; Hypoxia; Macrophage; pO2 histograph

Indexed keywords

IMMUNOGLOBULIN G;

ADENOCARCINOMA; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL HYPOXIA; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOCOMPETENT CELL; MACROPHAGE; MOUSE; NONHUMAN; OXYGEN TENSION; OXYGENATION; PREDICTION; PRIORITY JOURNAL; SARCOMA; SOLID TUMOR;

ANIMALS; CELL HYPOXIA; FEMALE; FLOW CYTOMETRY; FORECASTING; IMMUNOGLOBULIN G; MACROPHAGES; MICE; MICE, INBRED CBA; NEOPLASMS, EXPERIMENTAL; TUMOR CELLS, CULTURED;

EID: 0035793803     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1650     Document Type: Article

References (35)

1. Preclinical development and current status of the fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR4554 CRC 94/17): A non-invasive diagnostic probe for the measurement of tumour hypoxia by magnetic resonance spectroscopy and imaging, and by positron emission tomography
2. 11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis
3. Tumoar oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma
4. Cell selection from a murine tumour using the fluorescent probe Hoechst 33342
5. Measurement of tumour oxygenation: A comparison between polarographic needle electrodes and a time-resolved luminescence-based optical sensor
6. Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue
7. The molecular response of mammalian cells to hypoxia and the potential for exploitation in cancer therapy
8. 18F]EF1
9. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy
10. Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1
11. 2 predicts survival in advanced cancer of the uterine cervix
12. Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy
13. Mononuclear phagocyte system of the mouse defined by immunochemical localisation of antigen F4/80: Identification of resident macrophages in medullary and cortical interstitium and the juxtaglomemlar complex
14. Macrophages in human breast tumours: A quantitative immunohistochemical study
15. Cytokine networks in solid tumours: Regulation of angiogenesis
16. The role of macrophages in tumour angiogenesis
17. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast
18. Macrophage responses to hypoxia: Relevance to disease mechanisms
19. PR39, a peptide regulator of angiogenesis
20. The origin and function of tumour-associated macrophages
21. Combination of C. parvum and specific immunization against artificial pulmonary metastases in mice
22. Concomitant development of granulocytosis and enhancement of metastases formation in tumour-bearing mice
23. Macrophage content of murine sarcomas and carcinomas: Associations with tumour growth and tumour radiocurability
24. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck
25. 2 measurements by electron paramagnetic resonance oximetry
26. Tumour-associated leucocytes: Friends or foes in breast carcinoma
27. Distribution, oxygenation, and clonogenicity of macrophages in a murine tumour
28. Hypoxia inducible factor-1α is increased in ischaemic retina: Temporal and spatial correlation with VEGF expression
29. Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide
30. Isolation and characterisation of lymphocytes and macrophages from solid, malignant human tumours
31. Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumour cells
32. Reductive activation of nitroheterocyclic compounds
33. A new mouse tumour model system (RIF-1) for comparison of endpoint studies
34. On the mutagenicity of nitroimidazoles
35. Benzodiazepines and PK11195 exert immunomodulating activities by binding on a specific receptor on macrophages